Influenza Vaccines Market Growth, Analysis, Key Players, and Forecast to 2025Posted by rekha on October 31st, 2019 “The Global Influenza Vaccines Market is expected to reach US$ 6,679.8 Mn by 2025 owing to the increasing prevalence of influenza” The global influenza vaccines market is expected to reach US$ 6,679.8 Mn by 2025. Influenza is usually known as “flu” or “seasonal flu” triggered by influenza virus. The symptoms of influenza can be mild to severe ranging from fever to pneumonia. The global influenza vaccines market is driven by the rising prevalence of influenza. According to World Health Organization influenza affects about 3 to 5 million people globally of which there are cases of 290, 000 to 650, 000 respiratory deaths due to it. This virus generally spread through the air by coughing and sneezing or touching surfaces contaminated by a virus.WHO every year forecasts few strains which are expected to circulate in following year, that motivates pharmaceutical companies to develop influenza vaccine against these stains. Strict and mandatory government’s rule to take influenza vaccine as a preventive measure among different age group people is fueling the growth of global influenza vaccines market. Moreover reduced healthcare burden due to influenza vaccination expected to propel the market for influenza vaccine. However, Influenza vaccine made in a year may not be effective in following year owing to evolving nature of influenza virus, in healthy individual influenza vaccine is modestly effective, sometimes new strain or overlooked strain become prevalent in that season, and product recalls which may hamper the uptake and growth influenza vaccine market. Global influenza vaccines market is segmented on the basis of vaccine type, strain type, formulation type, distribution channel, and region. Request for Sample Report @ https://www.precisionbusinessinsights.com/request-sample?product_id=16918 Killed or Inactivated VaccinesDominate the Global Influenza Vaccines Market Based on the vaccine type, global influenza vaccines market is segmented into killed or inactivated and live vaccines. Killed or inactivated vaccines dominated the global influenza vaccines market. They produce strong immune response by holding inactivated genomic component and the surface of the virus which is exposed to the antigens that are important for strong immune response. Initiation of strong and long-lasting immune response will enhance the growth of this segment.
North America Leads the Global Influenza Vaccines Market PBI’s global influenza vaccines market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to regional analysis, North America dominated the global influenza vaccines market through 2014-2018 and expected to dominate over 2019-2025 owing to increase in prevalence of flu over there. The flu has resulted in 9.3 million to 49 million illnesses each year in the United States since 2010. It is estimated that the flu results in 31.4 million outpatient visits and more than 200,000 hospitalizations each year. Moreover, increase in research and development for new vaccines, and improved healthcare facilities are also aiding in the growth of the influenza vaccines market. Increased government support to stop the disease and to fine preventive measures is also bolstering the growth of influenza vaccines market in North America. Europe influenza vaccines market accounted for a significant share in global influenza vaccines market due to its increase in its prevalence among the European population. According to European Centre for Disease Prevention and Control around 60 % of European populations are affected with influenza virus. Moreover, development in healthcare infrastructure, and increase in disposable income in countries such as U.K, Germany etc. are also streaming the market growth in Europe region. Asia Pacific influenza vaccines market expected to grow significantly rate due to their emerging economies, increase in the prevalence of influenza virus, development of healthcare infrastructure, and technological advancements. As per Integrated Disease Surveillance Program (IDSP) under the National Centre for Disease Control a total of 38 811 laboratories confirmed cases and 2266 deaths were reported in the year 2017 in India. Launch of newer treatment therapies, and strategic alliances are the key strategies adopted by market players
Global Influenza Vaccines market further reveals that the key player’s increasingly adopting strategies such as launch of newer treatment therapies, and long term alliance to improve market revenue share and gaining significant geographic presence across the region.
Key player’s profiles in the report are GlaxoSmithKline plc., Seqirus (CSL Limited), AstraZeneca, Sanofi Pasteur Inc., Sinovac Biotech Ltd., Novavax, Inc., DAIICHI SANKYO COMPANY, LIMITED., Mitsubishi Tanabe Pharma., Protein Sciences Corporation. Precision Business Insights (PBI) in its report titled “Global Influenza Vaccines Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period over 2019-2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period. Detailed Segmentation
By Vaccine Type
By Strain Type
By Formulation Type
By Distribution Channel
Geography
o North America
o Europe
o Asia-Pacific
o Latin America
o Middle East and Africa (MEA)
For more information: https://www.precisionbusinessinsights.com/market-reports/global-influenza-vaccine-market/ Like it? Share it! More by this author |